Achieving path-dependent equity for global COVID-19 vaccine allocation

Committing to global access for COVID-19 vaccines is key to avoiding a resurgence of the pandemic. However, agreements between countries and vaccine manufacturers have undermined a globally coordinated approach, and the ongoing vaccine rollout highlights long-standing inequities in health. Yet, the...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Anthony D., Woo, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972793/
https://www.ncbi.nlm.nih.gov/pubmed/33758829
http://dx.doi.org/10.1016/j.medj.2021.03.004
_version_ 1783666717111615488
author So, Anthony D.
Woo, Joshua
author_facet So, Anthony D.
Woo, Joshua
author_sort So, Anthony D.
collection PubMed
description Committing to global access for COVID-19 vaccines is key to avoiding a resurgence of the pandemic. However, agreements between countries and vaccine manufacturers have undermined a globally coordinated approach, and the ongoing vaccine rollout highlights long-standing inequities in health. Yet, the surest path out of this pandemic is one toward greater equity.
format Online
Article
Text
id pubmed-7972793
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-79727932021-03-19 Achieving path-dependent equity for global COVID-19 vaccine allocation So, Anthony D. Woo, Joshua Med (N Y) Commentary Committing to global access for COVID-19 vaccines is key to avoiding a resurgence of the pandemic. However, agreements between countries and vaccine manufacturers have undermined a globally coordinated approach, and the ongoing vaccine rollout highlights long-standing inequities in health. Yet, the surest path out of this pandemic is one toward greater equity. Published by Elsevier Inc. 2021-04-09 2021-03-19 /pmc/articles/PMC7972793/ /pubmed/33758829 http://dx.doi.org/10.1016/j.medj.2021.03.004 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
So, Anthony D.
Woo, Joshua
Achieving path-dependent equity for global COVID-19 vaccine allocation
title Achieving path-dependent equity for global COVID-19 vaccine allocation
title_full Achieving path-dependent equity for global COVID-19 vaccine allocation
title_fullStr Achieving path-dependent equity for global COVID-19 vaccine allocation
title_full_unstemmed Achieving path-dependent equity for global COVID-19 vaccine allocation
title_short Achieving path-dependent equity for global COVID-19 vaccine allocation
title_sort achieving path-dependent equity for global covid-19 vaccine allocation
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972793/
https://www.ncbi.nlm.nih.gov/pubmed/33758829
http://dx.doi.org/10.1016/j.medj.2021.03.004
work_keys_str_mv AT soanthonyd achievingpathdependentequityforglobalcovid19vaccineallocation
AT woojoshua achievingpathdependentequityforglobalcovid19vaccineallocation

Ejemplares similares